Cargando…
Identification of 4-Amino-Thieno[2,3-d]Pyrimidines as QcrB Inhibitors in Mycobacterium tuberculosis
Antibiotic resistance is a global crisis that threatens our ability to treat bacterial infections, such as tuberculosis, caused by Mycobacterium tuberculosis. Of the 10 million cases of tuberculosis in 2017, approximately 19% of new cases and 43% of previously treated cases were caused by strains of...
Autores principales: | Harrison, Gregory A., Mayer Bridwell, Anne E., Singh, Megh, Jayaraman, Keshav, Weiss, Leslie A., Kinsella, Rachel L., Aneke, Janessa S., Flentie, Kelly, Schene, Miranda E., Gaggioli, Margaret, Solomon, Samantha D., Wildman, Scott A., Meyers, Marvin J., Stallings, Christina L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739496/ https://www.ncbi.nlm.nih.gov/pubmed/31511370 http://dx.doi.org/10.1128/mSphere.00606-19 |
Ejemplares similares
-
Improved Phenoxyalkylbenzimidazoles with Activity
against Mycobacterium tuberculosis Appear to Target
QcrB
por: Chandrasekera, N. Susantha, et al.
Publicado: (2017) -
Identification
of Morpholino Thiophenes as
Novel Mycobacterium tuberculosis Inhibitors, Targeting
QcrB
por: Cleghorn, Laura A. T., et al.
Publicado: (2018) -
Prediction of QcrB Inhibition as a Measure of Antitubercular
Activity with Machine Learning Protocols
por: Khan, Afreen A., et al.
Publicado: (2022) -
Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis
por: Foo, Caroline S., et al.
Publicado: (2018) -
Identification of Novel Imidazo[1,2-a]pyridine Inhibitors Targeting M. tuberculosis QcrB
por: Abrahams, Katherine A., et al.
Publicado: (2012)